Tirzepatide is the compound behind well-known pharmaceutical brands in the dual-agonist space and has been widely discussed in metabolic research communities
32 Acute glycaemic changes also affect gastric emptying
Maharjan R, Lim DS, Baik HJ, Park HE, Kim MS, Kim KH, et al
This oral preparation would offer a more convenient and comfortable option for patients, potentially leading to better treatment compliance.58,59 Overall, the future research direction of GLP-1RAs involves making them more similar to those in the human body, extending their duration of action, and creating oral formulations for easier administration.60,61 These advancements aim to improve patient experience, compliance, and treatment outcomes